Skip to main content
Fig.4 | Cancer Cell International

Fig.4

From: Knockdown of PGM1 enhances anticancer effects of orlistat in gastric cancer under glucose deprivation

Fig.4

Altered PGM1 expression affects glucose and lipid metabolism under glucose deprivation. a–d Colorimetry assays to measure glycolysis of BGC-823 and MKN-28 cells with knockdown of PGM1 or NC under the NG or LG condition, including lactate acid (a), pyruvic acid (b), ATP (c) production and glucose uptake capability (d). e WB assay to show protein expression levels of cells as in (a–d). f Colorimetry assay to measure FASN activity of cells as in (a–d). Data are shown as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. no significant. PGM1: Phosphoglucomutase 1; FASN: Fatty Acid Synthase; CPT1A: Carnitine Palmitoyltransferase 1A; ACC: Acetyl CoA Carboxylase; NC: negative control; NG: normal glucose, 10 mM glucose in medium; LG: low glucose, 2.5 mM glucose in medium; SD: standard deviation

Back to article page